About Jonathan Leff
Form D filings for Elion Therapeutics in 2024 list Jonathan Leff as director.
Jonathan Leff first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jonathan Leff in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jonathan Leff works with at each company, as listed on that company's latest Form D.
Elion Therapeutics, Inc. · Form D, Jun 26, 2024
